On the other hand, it was recently shown that TP53-mutated BC exhibits significantly higher expression of chronic inflammation markers (i.e interferon signaling, CD8 + T-cell infiltration) and immune checkpoints, indicating that TP53mut-targeting compounds could restore effective immune surveillance34. The gene discussed is CD8A; the disease is breast cancer.